Metabolomic Profiling of Plasma Reveals Differential Disease Severity Markers in COVID-19 Patients

Publisher’s Note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may.

Detalles Bibliográficos
Autores: Oliveira, Lucas Barbosa, Mwangi, Victor Irungu, Sartim, Marco Aurélio, Delafiori, Jeany, Sales, Geovana Manzan, Oliveira, Arthur Noin de, Busanello, Estela Natacha Brandt, Val, Fernando Fonseca de Almeida e, Xavier, Mariana Simão, Costa, Fábio Trindade, Baía-Da-Silva, Djane Clarys, Sampaio, Vanderson de Souza, Lacerda, Marcus Vinícius Guimarães de, Monteiro, Wuelton Marcelo, Catharino, Rodrigo Ramos, Melo, Gisely Cardoso de
Tipo de recurso: artículo
Estado:Versión publicada
Fecha de publicación:2022
País:Brasil
Institución:Fundação Oswaldo Cruz (FIOCRUZ)
Repositorio:Repositório Institucional da FIOCRUZ (ARCA)
Idioma:inglés
OAI Identifier:oai:arca.fiocruz.br:icict/63172
Acceso en línea:https://arca.fiocruz.br/handle/icict/63172
Access Level:acceso abierto
Palabra clave:Metabolomics
Mass spectrometry
COVID-19
SARS-CoV-2
Metabolites
Prognosis
Descripción
Sumario:Publisher’s Note: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may.

Similares en LA Referencia